期刊文献+

膀胱水扩张联合灌注树胶脂毒素治疗间质性膀胱炎的疗效分析 被引量:3

Intravesical instillation resiniferatoxin and hydrodistention for the treatment of interstitial cystitis
原文传递
导出
摘要 目的 评价使用腰麻下膀胱水扩张联合灌注树胶脂毒素(RTX)治疗间质性膀胱炎(IC)的疗效.方法 回顾性分析16例间质性膀胱炎患者,均使用腰麻下行水扩张加RTX膀胱灌注.评价治疗前、后1个月以及6个月的排尿次数,排尿量以及临床症状比较.结果 所有患者治疗前与治疗后1个月以及6个月的排尿频率、最大膀胱容量以及临床症状评分相比,均有明显改善差异有统计学意义(P<0.05).16例患者中14位患者有不同程度的症状改善.2例患者的临床症状消失或明显改善.结论 RTX膀胱灌注以及膀胱水扩张对于间质性膀胱炎是短期内安全有效改善症状的治疗方法. Objective To evaluate the efficacy of bladder hydredistention and resiniferatoxin(RTX)on treating female interstitial cystitis(IC).Methods A total of 16 patients with IC were included.All patients received cystoscopie hydrodistention and RTX under anesthesia.The O'Leary-Sant Interstitial Cystitis Symptom Index(ICSI),Problem Index(ICPI),voiding frequency and the maximum bladder capacity were recorded before and after the therapy.Results All patients were followed up for 1 or 6 months.Fourteen of 16patients'symptoms were relieved,2 patients symptoms disappeared or significantly relieved.Conclusion Bladder hydrodistention and RTX effectively relieve symptoms and improve quality of life in patients with IC in the short term.
出处 《国际外科学杂志》 2011年第5期310-312,共3页 International Journal of Surgery
关键词 间质性膀胱炎 膀胱扩张 树胶脂毒素 Interstitial cystitis Bladder hydrodistention Resiniferatoxin
  • 相关文献

参考文献5

  • 1Nickel JC,Teichman JM,Gregoire M,et al.Prevalence,diagnosis,characterization,and treatment of prostatitis,interstitial cystitis,and epididymitis in outpatient urological practice:the Canadian PIE Study[J].Urology,2005,66(5):935-940.
  • 2Gillenwater JY,Wein AJ.Summary of the National Institute of Arthritis,Diabetes,Digestive,and Kidney Disease Workshop on Interstitial Cystitis,National Institutes of Health,Bethesda,Maryland August 28-29,1987[J].J Urol,1988,140(1):203-206.
  • 3Szallasi A,Blumberg PM.Vanilloid(Capsaicin)receptors and mechanisms[J].Pharmacol Rev,1999,51(2):159-212.
  • 4Eriekson DR,Kunselman AR,Bentley CM,et al.Changes in urine markers and symptoms after bladder distention for interstitial cystitis[J].J Urol,2007,177(2):556-560.
  • 5Payne CK,Mosbaugh PG,Forrest JB,et al.Intravesical resiniferatoxin for the treatment of interstitial cystitis:a randomized,doubleblind,placebo controlled trial[J].J Urol,2005,173(5):1590-1594.

同被引文献44

  • 1Hanno PM, Burks DA, Clemens JQ, et al. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol, 2011, 185(6): 2162-2170.
  • 2Buffington CA. Comorbidity of interstitial cystitis with other unexplained clinical conditions. J Urol, 2004, 172 (4 pt 1): 1242-1248.
  • 3Christmas TJ, Rode J, Chapple CR, et al. Nerve fiber proliferation in interstitial cystitis. Virchows Arch A Pathol Anat Histopathol; 1990, 416(5): 447-451.
  • 4Parsons JK, Parsons CL. The historical origins of interstitial cystitis. J Urol, 2004, 171(1): 20-22.
  • 5Domingue GJ, Ghoniem GM, Bost KL, et al. Dormant microbes in interstitial cystitis. J Urol, 1995, 153(4): 1321-1326.
  • 6Sant GR, Kempuraj D, Marchand JE, et al. The mast cell in interstitial cystitis: Role in pathophysiology and pathogenesis. Urology, 2007, 69(4 suppl): 34-40.
  • 7Oravisto KJ, Alfthan OS, Jokinen EJ. Interstitial cystitis: Clinical and immunological findings. Scand J Urol Nephrol, 1970, 4(1): 37-42.
  • 8Parsons CL. The role the of urology epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis. Urology, 2007, 69 (d suppl): 9-16.
  • 9Parsons CL, Bautista SL, Stein PC, et al. Cyto-injury factors in urine: a possible mechanism for the development of interstitial cystitis. J Urol, 2000, 64(4): 1381-1384.
  • 10Sanders KM, Ward SM. Kit mutants and gastrointestinal physiology. J Physiol, 2007, 578(Pt 1): 33-42.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部